Real-world outcomes of patients with advanced non-small cell lung cancer treated with anti-PD1 therapy on the basis of PD-L1 Results in EBUS-TBNA vs. histological specimens.
Sign Up to like & getrecommendations! Published in 2021 at "Chest"
DOI: 10.1016/j.chest.2021.02.053
Abstract: BACKGROUND PD-L1 testing is feasible in a majority of specimens acquired using endobronchial ultrasound-guided needle aspiration (EBUS-TBNA). RESEARCH QUESTION Are the outcomes of patients with advanced NSCLC treated with immune checkpoint inhibitors (ICI) on the… read more here.
Keywords: basis; ebus tbna; results ebus; basis results ... See more keywords